The activation of μ-opioid receptor potentiates LPS- induced NF-kB promoting an inflammatory phenotype in microglia

被引:74
作者
Gessi, Stefania [1 ]
Borea, Pier Andrea [1 ]
Bencivenni, Serena [1 ]
Fazzi, Debora [1 ]
Varani, Katia [1 ]
Merighi, Stefania [1 ]
机构
[1] Univ Ferrara, Dept Med Sci, I-44100 Ferrara, Italy
关键词
Akt; mitogen-activated protein kinases; neuroinflammation; nuclear factor-kB; opioid receptor; PKCe; PROTEIN-KINASE-C; FACTOR-KAPPA-B; CHRONIC PAIN; PKC-EPSILON; MORPHINE; CELLS; EXPRESSION; TRANSCRIPTION; MECHANISMS; INHIBITION;
D O I
10.1002/1873-3468.12313
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increased production of proinflammatory cytokines has a prominent role in tolerance to opioids. The objectives of this study were to examine whether mu-opioid receptor affects proinflammatory signalling through the activation of NF-kB in microglia. The novelty of the described research is that a low dose of morphine, exerting its effects via the mu-opioid receptor, increases the DNA-binding activity of NF-kB via PKC epsilon, while a high dose of morphine triggers a nonopiate receptor response mediated by TLR4 and, interestingly, PKC epsilon signalling. The identification of morphine as a crucial upstream regulator of PKC epsilon-NF-kappa B signalling in microglia argues for a central role of these pathways in neuroinflammation development and progression. Therefore, the morphine-PKC epsilon-NF-kappa B pathway may provide novel targets to induce neuroprotective mechanisms, thereby reducing tolerance to opioids.
引用
收藏
页码:2813 / 2826
页数:14
相关论文
共 50 条
[1]   Preclinical Development of a Bifunctional Cancer Cell Homing, PKCε Inhibitory Peptide for the Treatment of Head and Neck Cancer [J].
Bao, Liwei ;
Gorin, Michael A. ;
Zhang, Manchao ;
Ventura, Alejandra C. ;
Pomerantz, William C. ;
Merajver, Sofia D. ;
Teknos, Theodoros N. ;
Mapp, Anna K. ;
Pan, Quintin .
CANCER RESEARCH, 2009, 69 (14) :5829-5834
[2]   Inhibition of NF-κB by Opioids in T Cells [J].
Boerner, Christine ;
Kraus, Juergen .
JOURNAL OF IMMUNOLOGY, 2013, 191 (09) :4640-4647
[3]   Mechanisms of the Inhibition of Nuclear Factor-κB by Morphine in Neuronal Cells [J].
Boerner, Christine ;
Hoellt, Volker ;
Kraus, Juergen .
MOLECULAR PHARMACOLOGY, 2012, 81 (04) :587-597
[4]   Peptides derived from the C2 domain of protein kinase Cε (εPKC) modulate εPKC activity and identify potential protein-protein interaction surfaces [J].
Brandman, Relly ;
Disatnik, Marie-Helene ;
Churchill, Eric ;
Mochly-Rosen, Daria .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (06) :4113-4123
[5]   Sotrastaurin, a Novel Small Molecule Inhibiting Protein Kinase C: First Clinical Results in Renal-Transplant Recipients [J].
Budde, K. ;
Sommerer, C. ;
Becker, T. ;
Asderakis, A. ;
Pietruck, F. ;
Grinyo, J. M. ;
Rigotti, P. ;
Dantal, J. ;
Ng, J. ;
Barten, M. J. ;
Weber, M. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (03) :571-581
[6]   Protein kinase Cε is required for macrophage activation and defense against bacterial infection [J].
Castrillo, A ;
Pennington, DJ ;
Otto, F ;
Parker, PJ ;
Owen, MJ ;
Boscá, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (09) :1231-1242
[7]   Nuclear Factor κB Signaling in Opioid Functions and Receptor Gene Expression [J].
Chen, Yulong L. ;
Law, Ping-Yee ;
Loh, Horace H. .
JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2006, 1 (03) :270-279
[8]   The atypical PKCs in inflammation: NF-κB and beyond [J].
Diaz-Meco, Maria T. ;
Moscat, Jorge .
IMMUNOLOGICAL REVIEWS, 2012, 246 :154-167
[9]   Toll-like receptors: From the discovery of NFKB to new insights into transcriptional regulations in innate immunity [J].
Doyle, Sarah L. ;
O'Neill, Luke A. J. .
BIOCHEMICAL PHARMACOLOGY, 2006, 72 (09) :1102-1113
[10]   Morphine Exacerbates HIV-1 Tat-Induced Cytokine Production in Astrocytes through Convergent Effects on [Ca2+]i, NF-κB Trafficking and Transcription [J].
El-Hage, Nazira ;
Bruce-Keller, Annadora J. ;
Yakovleva, Tatiana ;
Bazov, Igor ;
Bakalkin, Georgy ;
Knapp, Pamela E. ;
Hauser, Kurt F. .
PLOS ONE, 2008, 3 (12)